Back

Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction

15 April 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Let´s look at 2020´s most downloaded articles in the European Journal of Preventive Cardiology (EJPC) Risk Factors and Prevention EAPC Premium Access ESC Preventive Cardiology 2021

About the speaker

Photo
Mr Guilherme Neif Vieira Musse

Paulista State University (UNESP), Sao Paulo (Brazil)

7 More presentations in this session

Presentation thumbnail
Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction - Commentary
Professor M. Minicucci (Botucatu, BR)
Video
Presentation thumbnail
Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction - discussion
Presentation thumbnail
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
Doctor C. Ballantyne (Houston, US)
Video
Presentation thumbnail
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy - Commentary.
Professor U. Landmesser (Berlin, DE)
Presentation thumbnail
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy - Discussion

Access the full session

Session thumbnail
Let´s look at 2020´s most downloaded articles in the European Journal of Preventive Cardiology (EJPC)
Video

The Event

Event poster

ESC Preventive Cardiology 2021

15 April - 17 April 2021
You may be interested in
thumbnail
Congress Presentation
Making personalised prevention everyone's business
thumbnail
Congress Presentation
Cardiovascular prevention in older adults
thumbnail
Congress Presentation
State-of-the-art lecture on closing the evidence-to-practice gap in cardiovascular pharmacotherapy: where are we still failing?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources